Sacha Gnjatic

41.2k total citations · 7 hit papers
223 papers, 16.8k citations indexed

About

Sacha Gnjatic is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Sacha Gnjatic has authored 223 papers receiving a total of 16.8k indexed citations (citations by other indexed papers that have themselves been cited), including 166 papers in Immunology, 99 papers in Oncology and 77 papers in Molecular Biology. Recurrent topics in Sacha Gnjatic's work include Immunotherapy and Immune Responses (151 papers), Cancer Immunotherapy and Biomarkers (67 papers) and Immune Cell Function and Interaction (48 papers). Sacha Gnjatic is often cited by papers focused on Immunotherapy and Immune Responses (151 papers), Cancer Immunotherapy and Biomarkers (67 papers) and Immune Cell Function and Interaction (48 papers). Sacha Gnjatic collaborates with scholars based in United States, Germany and Switzerland. Sacha Gnjatic's co-authors include Lloyd J. Old, Gerd Ritter, Achim A. Jungbluth, Yao‐Tseng Chen, Kunle Odunsi, Elke Jäger, Shashikant Lele, Feng Qian, Hiroyoshi Nishikawa and Alexander Knuth and has published in prestigious journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Sacha Gnjatic

217 papers receiving 16.6k citations

Hit Papers

Intraepithelial CD8+tumor-infiltrating lymphocytes and a ... 2005 2026 2012 2019 2005 2021 2008 2010 2018 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Intraepithelial CD8+tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
    2005 1.9k citations Eiichi Sato, Hiroyoshi Nishikawa et al. profile →
  2. PD-L1 as a biomarker of response to immune-checkpoint inhibitors
    2021 980 citations Sacha Gnjatic et al. profile →
  3. Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1
    2008 704 citations Achim A. Jungbluth, Sacha Gnjatic et al. profile →
  4. Tumor-infiltrating NY-ESO-1–specific CD8 + T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer
    2010 695 citations Junko Matsuzaki, Sacha Gnjatic et al. profile →
  5. Radiotherapy induces responses of lung cancer to CTLA-4 blockade
    2018 640 citations Silvia C. Formenti, Nils-Petter Rudqvist et al. Nature Medicine profile →
  6. Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer
    2014 598 citations Sacha Gnjatic et al. profile →
  7. Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
    2011 254 citations Jianda Yuan, Erika Ritter et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sacha Gnjatic United States 61 11.6k 9.8k 5.0k 1.8k 1.4k 223 16.8k
Alan J. Korman United States 55 10.2k 0.9× 10.0k 1.0× 2.8k 0.6× 1.5k 0.9× 1.6k 1.1× 113 15.6k
Gavin P. Dunn United States 45 8.9k 0.8× 8.4k 0.9× 4.2k 0.8× 1.8k 1.0× 894 0.7× 136 16.4k
Michele W.L. Teng Australia 56 8.3k 0.7× 9.2k 0.9× 3.6k 0.7× 1.9k 1.1× 588 0.4× 95 15.0k
Daniel E. Speiser Switzerland 77 16.8k 1.5× 10.7k 1.1× 6.4k 1.3× 1.3k 0.7× 928 0.7× 310 23.1k
James W. Hodge United States 61 7.9k 0.7× 7.8k 0.8× 2.7k 0.5× 2.5k 1.4× 1.4k 1.0× 196 12.3k
Dallas B. Flies United States 38 10.6k 0.9× 9.4k 1.0× 2.3k 0.5× 1.3k 0.7× 614 0.4× 65 14.9k
Michele Maio Italy 66 6.9k 0.6× 11.4k 1.2× 7.3k 1.5× 3.3k 1.9× 1.1k 0.8× 376 18.5k
Sergio A. Quezada United Kingdom 45 7.5k 0.6× 7.5k 0.8× 3.0k 0.6× 1.8k 1.0× 639 0.5× 97 12.6k
Alexander Knuth Germany 63 11.0k 0.9× 7.3k 0.7× 7.4k 1.5× 2.1k 1.2× 2.3k 1.7× 245 18.4k
Esteban Celis United States 63 13.5k 1.2× 8.6k 0.9× 5.4k 1.1× 1.2k 0.7× 1.3k 1.0× 205 18.7k

Countries citing papers authored by Sacha Gnjatic

Since Specialization
Citations

This map shows the geographic impact of Sacha Gnjatic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sacha Gnjatic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sacha Gnjatic more than expected).

Fields of papers citing papers by Sacha Gnjatic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sacha Gnjatic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sacha Gnjatic. The network helps show where Sacha Gnjatic may publish in the future.

Co-authorship network of co-authors of Sacha Gnjatic

This figure shows the co-authorship network connecting the top 25 collaborators of Sacha Gnjatic. A scholar is included among the top collaborators of Sacha Gnjatic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sacha Gnjatic. Sacha Gnjatic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bozkus, Cansu Cimen, Julia Kodysh, Simon K. Cheng, et al.. (2024). CTIM-10. PHASE 1 TRIAL OF PERSONALIZED NEOANTIGEN VACCINES IN COMBINATION WITH STANDARD CARE TO TREAT GLIOBLASTOMA. Neuro-Oncology. 26(Supplement_8). viii86–viii87. 1 indexed citations
2.
Aggarwal, Charu, Daniel H. Sterman, Erin R. Alesi, et al.. (2024). Overall survival after treatment with CAN-2409 plus valacyclovir in combination with continued ICI in patients with stage III/IV NSCLC with an inadequate response to ICI.. Journal of Clinical Oncology. 42(16_suppl). 8634–8634. 6 indexed citations
3.
Hughes, Kelly T., Güray Aktürk, Sacha Gnjatic, et al.. (2020). Proliferation of HIV-infected renal epithelial cells following virus acquisition from infected macrophages. AIDS. 34(11). 1581–1591. 18 indexed citations
4.
Somaiah, Neeta, Matthew S. Block, Joseph W. Kim, et al.. (2019). First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1. Clinical Cancer Research. 25(19). 5808–5817. 71 indexed citations
5.
Cohen, Adam D., Nikoletta Lendvai, Sarah Nataraj, et al.. (2019). Autologous Lymphocyte Infusion Supports Tumor Antigen Vaccine–Induced Immunity in Autologous Stem Cell Transplant for Multiple Myeloma. Cancer Immunology Research. 7(4). 658–669. 14 indexed citations
6.
Perumal, Deepak, Naoko Imai, Alessandro Laganà, et al.. (2019). Mutation-derived Neoantigen-specific T-cell Responses in Multiple Myeloma. Clinical Cancer Research. 26(2). 450–464. 59 indexed citations
7.
Pavlick, Anna C., Ana-Belén Blázquez, Marcia Meseck, et al.. (2019). Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma. Cancer Immunology Research. 8(1). 70–80. 56 indexed citations
8.
Formenti, Silvia C., Nils-Petter Rudqvist, Encouse B. Golden, et al.. (2018). Radiotherapy induces responses of lung cancer to CTLA-4 blockade. Nature Medicine. 24(12). 1845–1851. 640 indexed citations breakdown →
9.
Parikh, Falguni, Dorothée Duluc, Naoko Imai, et al.. (2014). Chemoradiotherapy-Induced Upregulation of PD-1 Antagonizes Immunity to HPV-Related Oropharyngeal Cancer. Cancer Research. 74(24). 7205–7216. 83 indexed citations
10.
Karbach, Julia, Sacha Gnjatic, Akin Atmaca, et al.. (2014). Long-term Complete Remission Following Radiosurgery and Immunotherapy in a Melanoma Patient with Brain Metastasis: Immunologic Correlates. Cancer Immunology Research. 2(5). 404–409. 12 indexed citations
11.
Odunsi, Kunle, Junko Matsuzaki, Smitha R. James, et al.. (2014). Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer. Cancer Immunology Research. 2(1). 37–49. 153 indexed citations
12.
Tsuji, Takemasa, Paul Sabbatini, Achim A. Jungbluth, et al.. (2013). Effect of Montanide and Poly-ICLC Adjuvant on Human Self/Tumor Antigen-Specific CD4+ T Cells in Phase I Overlapping Long Peptide Vaccine Trial. Cancer Immunology Research. 1(5). 340–350. 52 indexed citations
13.
Matsuzaki, Junko, Takemasa Tsuji, Immanuel F. Luescher, et al.. (2013). Nonclassical Antigen-Processing Pathways Are Required for MHC Class II–Restricted Direct Tumor Recognition by NY-ESO-1–Specific CD4+ T Cells. Cancer Immunology Research. 2(4). 341–350. 38 indexed citations
14.
Kitano, Shigehisa, Takemasa Tsuji, Daniel Hirschhorn-Cymerman, et al.. (2013). Enhancement of Tumor-Reactive Cytotoxic CD4+ T-cell Responses after Ipilimumab Treatment in Four Advanced Melanoma Patients. Cancer Immunology Research. 1(4). 235–244. 96 indexed citations
15.
Karbach, Julia, Antje Neumann, Kathrin Brand, et al.. (2012). Phase I Clinical Trial of Mixed Bacterial Vaccine (Coley's Toxins) in Patients with NY-ESO-1 Expressing Cancers: Immunological Effects and Clinical Activity. Clinical Cancer Research. 18(19). 5449–5459. 79 indexed citations
16.
Karbach, Julia, Antje Neumann, Claudia Wahle, et al.. (2012). Therapeutic Administration of a Synthetic CpG Oligodeoxynucleotide Triggers Formation of Anti-CpG Antibodies. Cancer Research. 72(17). 4304–4310. 18 indexed citations
17.
Halama, Niels, Sara Michel, Matthias Kloor, et al.. (2011). Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy. Cancer Research. 71(17). 5670–5677. 321 indexed citations
18.
Gnjatic, Sacha, Nasser K. Altorki, Derek Ng Tang, et al.. (2009). NY-ESO-1 DNA Vaccine Induces T-Cell Responses That Are Suppressed by Regulatory T Cells. Clinical Cancer Research. 15(6). 2130–2139. 58 indexed citations
19.
Nishikawa, Hiroyoshi, Takuma Kato, Yuki Orito, et al.. (2008). Regulatory T Cell–Resistant CD8+ T Cells Induced by Glucocorticoid-Induced Tumor Necrosis Factor Receptor Signaling. Cancer Research. 68(14). 5948–5954. 66 indexed citations
20.
Güre, Ali O., Ramon Chua, Barbara Williamson, et al.. (2005). Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer. Clinical Cancer Research. 11(22). 8055–8062. 294 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alan J. Korman Breakdown of academic impact, for papers by Gavin P. Dunn Breakdown of academic impact, for papers by Michele W.L. Teng Breakdown of academic impact, for papers by Daniel E. Speiser Breakdown of academic impact, for papers by James W. Hodge Breakdown of academic impact, for papers by Dallas B. Flies Breakdown of academic impact, for papers by Michele Maio Breakdown of academic impact, for papers by Sergio A. Quezada Breakdown of academic impact, for papers by Alexander Knuth Breakdown of academic impact, for papers by Esteban Celis
Rankless by CCL
2026